Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daphne Stewart

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The Oncologist|March 21, 2023
Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast CancerXuan Ge, Carolyn E Behrendt, Susan E Yost, et al.
Plos One|June 13, 2023
BRCA germline mutations in multiethnic gynecologic patients: A 10-year retrospective analysis from a single cancer instituteChristina H Wei, Susan Shehayeb, Nicole Lugo Santiago, et al.
Journal of Clinical Medicine|July 1, 2020
Use of HER2-Directed Therapy in Metastatic Breast Cancer and How Community Physicians Collaborate to Improve CareJoanne E Mortimer, Laura Kruper, Mary Cianfrocca, et al.
Journal for Immunotherapy of Cancer|January 12, 2025
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancerNehal J Lakhani, Daphne Stewart, Debra L Richardson, et al.
The Oncologist|April 6, 2023
Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast CancerYuan Yuan, Susan E Yost, Yujie Cui, et al.
Journal of Clinical Medicine|September 5, 2020
Frontline Management of Epithelial Ovarian Cancer-Combining Clinical Expertise with Community Practice Collaboration and Cutting-Edge ResearchEdward Wenge Wang, Christina Hsiao Wei, Sariah Liu, et al.
Journal of Clinical Medicine|March 11, 2023
Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast CancerDana Mahin, Sayeh Moazami Lavasani, Leon Cristobal, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2025
MammaTrace - a cell-free DNA methylation plasma only assay for minimal residual disease detection in breast cancer patientsDavid N Buckley, Alex J Kalfa, Gerald Gooden, et al.
Cancers|September 9, 2022
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast CancerXuan Ge, Susan E Yost, Jin Sun Lee, et al.
Gynecologic Oncology|January 23, 2024
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancerMihaela C Cristea, Daphne Stewart, Timothy Synold, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Oncologist|March 21, 2023
Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast CancerXuan Ge, Carolyn E Behrendt, Susan E Yost, et al.
Plos One|June 13, 2023
BRCA germline mutations in multiethnic gynecologic patients: A 10-year retrospective analysis from a single cancer instituteChristina H Wei, Susan Shehayeb, Nicole Lugo Santiago, et al.
Journal of Clinical Medicine|July 1, 2020
Use of HER2-Directed Therapy in Metastatic Breast Cancer and How Community Physicians Collaborate to Improve CareJoanne E Mortimer, Laura Kruper, Mary Cianfrocca, et al.
Journal for Immunotherapy of Cancer|January 12, 2025
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancerNehal J Lakhani, Daphne Stewart, Debra L Richardson, et al.
The Oncologist|April 6, 2023
Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast CancerYuan Yuan, Susan E Yost, Yujie Cui, et al.
Journal of Clinical Medicine|September 5, 2020
Frontline Management of Epithelial Ovarian Cancer-Combining Clinical Expertise with Community Practice Collaboration and Cutting-Edge ResearchEdward Wenge Wang, Christina Hsiao Wei, Sariah Liu, et al.
Journal of Clinical Medicine|March 11, 2023
Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast CancerDana Mahin, Sayeh Moazami Lavasani, Leon Cristobal, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2025
MammaTrace - a cell-free DNA methylation plasma only assay for minimal residual disease detection in breast cancer patientsDavid N Buckley, Alex J Kalfa, Gerald Gooden, et al.
Cancers|September 9, 2022
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast CancerXuan Ge, Susan E Yost, Jin Sun Lee, et al.
Gynecologic Oncology|January 23, 2024
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancerMihaela C Cristea, Daphne Stewart, Timothy Synold, et al.
Pageof 3